Log in
Enquire now
‌

Cytospire Therapeutics

Cytospire Therapeutics is an antibodies developer for cancer treatment founded in 2023.

OverviewStructured DataIssuesContributors

Contents

cytospire.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Health technology
Health technology
CEO
‌
Natalie Mount
Number of Employees (Ranges)
11 – 50
Email Address
contact@cytospiretx.com
Investors
‌
Medical Incubator Japan
Abingworth
Abingworth
British Business Bank PLC
British Business Bank PLC
‌
Servier
4BIO Capital
4BIO Capital
Pathway Bioventures
Pathway Bioventures
Sound Bioventures
Sound Bioventures
‌
Modi Ventures
...
Founded Date
2023
Total Funding Amount (USD)
83,000,000
Latest Funding Round Date
May 5, 2026
CTO
‌
Mark Uden
Latest Funding Type
Series A
Series A
Country
United Kingdom
United Kingdom
Headquarters
London
London

Other attributes

Latest Funding Round Amount (USD)
83,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Cytospire Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.